UIM5:F:F- (EUR)

ETF | Others |

Last Closing

USD 45.333

Change

+0.54 (+1.21)%

Market Cap

USD 105.67B

Volume

600.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-08 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 101.74B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.47 (-0.90%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.20 (-1.42%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

+0.12 (+1.62%)

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

-3.24 (-3.57%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 45.80B
0ZC:F Zscaler Inc

-0.40 (-0.22%)

USD 37.92B
BSND:F Danone SA

-0.20 (-1.40%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B
SXRV:F iShares NASDAQ 100 UCITS ETF U..

-29.30 (-3.07%)

USD 15.02B

ETFs Containing UIM5:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -13.27% 32% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -13.27% 32% F 45% F
Trailing 12 Months  
Capital Gain -12.00% 21% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -12.00% 19% F 40% F
Trailing 5 Years  
Capital Gain 24.11% 43% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.11% 43% F 34% F
Average Annual (5 Year Horizon)  
Capital Gain 6.11% 55% F 56% F
Dividend Return 6.17% 52% F 48% F
Total Return 0.06% 5% F 2% F
Risk Return Profile  
Volatility (Standard Deviation) 11.04% 61% D- 89% A-
Risk Adjusted Return 55.85% 55% F 68% D+
Market Capitalization 105.67B 100% F 98% N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.